rxstat › Shortages › Esculin Framycetin Dibucaine Hydrocortisone
Esculin Framycetin Dibucaine Hydrocortisone shortage status
No current shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Esculin Framycetin Dibucaine Hydrocortisone has no current shortage reported in Canada. It has been in shortage before; the history is below.
Reports by product
DiscontinuedTEVA-PROCTOSONE
1%
1%
0.5%
0.5% · OINTMENT · TEVA CANADA LIMITED
DIN 02226383
ResolvedTEVA-PROCTOSONE
5MG
5MG
10MG
10MG · OINTMENT · TEVA CANADA LIMITED
DIN 02226383 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
ResolvedTEVA-PROCTOSONE
5MG
5MG
10MG
10MG · OINTMENT · TEVA CANADA LIMITED
DIN 02226383 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
DiscontinuedPROCTOSEDYL
1%
1%
0.5%
0.5% · OINTMENT · APTALIS PHARMA CANADA ULC
DIN 02223252
DiscontinuedODAN PROCTOMYXIN HC
1%
1%
0.5%
0.5% · OINTMENT · ODAN LABORATORIES LTD
DIN 02242527
DiscontinuedODAN PROCTOMYXIN HC SUPPOSITORIES
10MG
5MG
10MG
5MG · SUPPOSITORY · ODAN LABORATORIES LTD
DIN 02242528
ResolvedSANDOZ PROCTOMYXIN HC
0.5%
0.5%
1%
1% · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Aug 5, 2021 · Disruption of the manufacture of the drug.
ResolvedSANDOZ PROCTOMYXIN HC
0.5%
0.5%
1%
1% · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Jan 8, 2021 · Delay in shipping of the drug.
ResolvedSANDOZ PROCTOMYXIN HC SUPPOSITORIES
5MG
10MG
5MG
10MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02242528 · ended Oct 16, 2020 · Delay in shipping of the drug.
ResolvedSANDOZ PROCTOMYXIN HC
5MG
5MG
10MG
10MG · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Jan 20, 2020 · Demand increase for the drug.
ResolvedSANDOZ PROCTOMYXIN HC SUPPOSITORIES
5MG
5MG
10MG
10MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02242528 · ended Feb 4, 2020 · Demand increase for the drug.
ResolvedPROCTOSEDYL
5MG
10MG
5MG
10MG · OINTMENT · APTALIS PHARMA CANADA ULC
DIN 02223252 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Esculin Framycetin Dibucaine Hydrocortisone. Health Canada has 17 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Esculin Framycetin Dibucaine Hydrocortisone is classified under “AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE” (ATC C05AA).
Recent changes
Common questions
When will Esculin Framycetin Dibucaine Hydrocortisone be back in stock in Canada?
Esculin Framycetin Dibucaine Hydrocortisone has no active shortage; supply is normal per Health Canada reports.
Why is Esculin Framycetin Dibucaine Hydrocortisone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.